Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Accumulated Expenses (2020 - 2024)

Neuroone Medical Technologies (NMTC) has disclosed Other Accumulated Expenses for 5 consecutive years, with $258244.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Accumulated Expenses rose 2482.44% year-over-year to $258244.0, compared with a TTM value of $258244.0 through Dec 2024, up 2482.44%, and an annual FY2024 reading of $59950.0, changed N/A over the prior year.
  • Other Accumulated Expenses was $258244.0 for Q4 2024 at Neuroone Medical Technologies, up from $59950.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $258244.0 in Q4 2024 and bottomed at $10000.0 in Q4 2023.
  • Average Other Accumulated Expenses over 5 years is $92432.7, with a median of $59950.0 recorded in 2024.
  • The sharpest move saw Other Accumulated Expenses crashed 83.6% in 2022, then skyrocketed 2482.44% in 2024.
  • Year by year, Other Accumulated Expenses stood at $218125.0 in 2020, then plummeted by 61.88% to $83152.0 in 2021, then plummeted by 73.54% to $22001.0 in 2022, then crashed by 54.55% to $10000.0 in 2023, then surged by 2482.44% to $258244.0 in 2024.
  • Business Quant data shows Other Accumulated Expenses for NMTC at $258244.0 in Q4 2024, $59950.0 in Q3 2024, and $17007.0 in Q1 2024.